Cardioneuroablation and Ventricular Proarrhythmia

Recruiting N/A Interventional Study
Syncope, Vasovagal
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
14 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
50 (estimated)
Sponsor
Centre of Postgraduate Medical Education · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cardioneuroablation (CNA) is a promising tool to treat patients with asystolic reflex syncope. CNA acts through complete or near complete abolition of vagal nerve chronotropic and dromotropic effects on the heart, resulting in sinus node acceleration and improved atrio-ventricular conduction, which in turn prevents vagally-mediated reflex asystole. However, lack of parasympathetic protection may p…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * severe, recurrent symptoms due to reflex syncope with ECG documented asystole \>3 seconds * history of ineffective prior non-pharmacological treatment * positive baseline atropine test (sinus rate acceleration \> 30% and no atrio-ventricular block following 2 mg of intravenous…
Contacts

Piotr Kulakowski, MD PhD

+48 22 5152757

kulak@kkcmkp.pl

CONTACT

Agnieszka Sikorska, MD PhD

+48 22 5152757

sikorska.agnieszka.anna@gmail.com

CONTACT